NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: ARTEMISMED · data 2026-10-30
Artemis Medicare Services Ltd.
In plain words
Price: 22.6% below its 52-week high of ₹378.8.
Delivery: 51.1% of traded shares were kept for delivery over the last 10 sessions, against 47.8% over the last 60.
Latest results: a net profit of ₹31 cr for the quarter ended Sept 2026 (+3.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,114 cr |
| Net profit (last 12 months) | ₹114 cr |
| Sales growth, 3 years (yearly) | 13.6% |
| Profit growth, 3 years (yearly) | 39.0% |
At a glance
Promoters 58.4% (-8.1 pts in a year), pledged 0.0%, institutions 14.4%.
P/E 39.8, dividend yield 0.1%. Price relative to earnings and book value (low is cheaper, not better).
ROE 11.7%, ROCE 12.0%, operating margin 13.8%: how much profit it earns on the money it uses.
Debt/equity 0.28, Profit growth 39.0% and sales growth 13.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 39.0% a year over 3 years.
- Promoters cut their holding by 8.1 points in a year.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
ARTEMISMED Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹311.04 crore, up 13.2% YoY and up 8.3% QoQ.
Net profit was ₹31.03 crore, up 3.5% YoY and down 0.9% QoQ.
Operating margin was 17.6% (18.4% a year ago).
EPS was ₹1.96, up 3.2% YoY and down 1% QoQ.
ARTEMISMED के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹311.04 करोड़; पिछले साल की तुलना में 13.2% की बढ़त, पिछली तिमाही की तुलना में 8.3% की बढ़त।
शुद्ध मुनाफ़ा: ₹31.03 करोड़; पिछले साल की तुलना में 3.5% की बढ़त, पिछली तिमाही की तुलना में 0.9% की गिरावट।
ऑपरेटिंग मार्जिन: 17.6% (एक साल पहले 18.4%)।
EPS: ₹1.96; पिछले साल की तुलना में 3.2% की बढ़त, पिछली तिमाही की तुलना में 1% की गिरावट।
ARTEMISMEDના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹311.04 કરોડ; ગયા વર્ષની સરખામણીએ 13.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 8.3% વધારો.
ચોખ્ખો નફો: ₹31.03 કરોડ; ગયા વર્ષની સરખામણીએ 3.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 0.9% ઘટાડો.
ઓપરેટિંગ માર્જિન: 17.6% (એક વર્ષ પહેલાં 18.4%).
EPS: ₹1.96; ગયા વર્ષની સરખામણીએ 3.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 1% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
15/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 51.6% over the last 20 sessions vs 25.3% in the 40 before (2.04x); shares delivered per day 0.53x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 30 Oct 26Results Q2 FY27 results: profit +3.5% YoY
- 3 Aug 26Results Q1 FY27 results: profit +47.1% YoY +1.1% next session
- 10 Jul 26Dividend Dividend ₹0.45 (ex-date) +3.5% next session
- 8 May 26Results Q4 FY26 results: profit +30.4% YoY +6.2% next session
- 2 Feb 26Results Q3 FY26 results: profit +8.1% YoY -11.8% next session
- 11 Nov 25Results Q2 FY26 results: profit +34.6% YoY +9.8% next session
- 5 Aug 25Results Q1 FY26 results: profit +27.7% YoY -0.8% next session
- 11 Jul 25Dividend Dividend ₹0.45 (ex-date) -1.2% next session
- 12 May 25Results Q4 FY25 results: profit +62.4% YoY +3.1% next session
- 5 Feb 25Results Q3 FY25 results: profit +79.0% YoY -8.5% next session
- 14 Nov 24Results Q2 FY25 results: profit +63.8% YoY +3.9% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹311 cr | ₹31 cr | +3.5% | 17.6% | 1.96 |
| Jun 2026 | ₹287 cr | ₹31 cr | +47.1% | 19.6% | 1.98 |
| Mar 2026 | ₹279 cr | ₹30 cr | +30.4% | 18.5% | 1.9 |
| Dec 2025 | ₹272 cr | ₹22 cr | +8.1% | 16.4% | 1.41 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 58.39% | 58.39% | 58.39% | 58.39% |
| Foreign institutions (FII) | 12.46% | 12.29% | 12.19% | 12.47% |
| Domestic institutions (DII) | 1.91% | 2.40% | 2.89% | 2.91% |
| Mutual funds | 0.92% | 1.30% | 1.69% | 1.69% |
| Retail investors | 12.28% | 11.51% | 11.08% | 10.84% |
| Number of shareholders | 44,260 | 36,335 | 32,044 | 31,602 |
Common questions
What was Artemis Medicare Services Ltd.'s latest quarterly profit?
Artemis Medicare Services Ltd. reported a net profit of ₹31 cr for the quarter ended Sept 2026 (+3.5% on the same quarter a year earlier), on revenue of ₹311 cr.
How much do promoters hold in Artemis Medicare Services Ltd.?
Promoters held 58.39% of Artemis Medicare Services Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Artemis Medicare Services Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.28.
What is Artemis Medicare Services Ltd.'s P/E ratio?
About 39.8, based on the last 12 months' earnings and a price of ₹293.2 (data 2026-10-30).
What is the 52-week high and low of Artemis Medicare Services Ltd.?
The 52-week high is ₹378.8 and the 52-week low is ₹203.35.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Artemis Medicare Services Ltd. | ₹293.2 | ₹4,721 cr | 39.8 | — | 11.7% | 12% | 0.28 | +19.2% |
| HealthCare Global Enterprises Ltd. | ₹585.55 | ₹8,731 cr | 375.2 | — | 1.2% | 8.3% | 1.3 | -22.8% |
| Jupiter Life Line Hospitals Ltd. | ₹257.15 | ₹8,402 cr | 45.2 | 5.2 | 13.4% | 13.2% | 0.38 | -17.5% |
| Paras Healthcare Limited | ₹740.6 | ₹7,963 cr | — | 18.9 | 13% | 13.8% | 3.53 | +2.9% |
| Kovai Medical Center & Hospital Ltd. | ₹5,816 | ₹6,356 cr | 25.2 | — | 20.3% | 20.6% | 0.31 | +131.5% |
| Indraprastha Medical Corporation Limited | ₹305.65 | ₹2,797 cr | 14.9 | — | 27.5% | 30% | 0.05 | -46.9% |
Compare ARTEMISMED with HCG in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ARTEMISMED in NSE Scanner →